BioNeutra Global Corporation
IEGH.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 45.38% | 10.40% | -160.37% | 202.72% | -7.98% |
| Total Depreciation and Amortization | -232.98% | -6.72% | -26.81% | 9.12% | 20.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.54% | -3.93% | 171.95% | -294.68% | 1,304.00% |
| Change in Net Operating Assets | -14.60% | 202.71% | 49.76% | -193.91% | 67.12% |
| Cash from Operations | -87.75% | 126.56% | -593.70% | -41.68% | 246.83% |
| Capital Expenditure | 75.57% | -- | -- | -125.00% | 79.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Investing | 75.57% | -- | -- | -44.00% | 67.53% |
| Total Debt Issued | -- | -- | -- | 236.96% | 1,261.54% |
| Total Debt Repaid | -10.56% | 4.72% | 9.49% | -11.30% | -58.36% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -85.42% | 66.08% | 60.31% | -62,487.50% | 0.00% |
| Cash from Financing | -42.86% | 46.95% | -156.01% | 114.99% | 809.02% |
| Foreign Exchange rate Adjustments | 468.14% | -55.43% | -130.69% | 239.22% | -260.03% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 485.24% | 92.03% | -230.46% | 228.34% | 372.62% |
